Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
		
    Selenium does not affect radiosensitivity of breast cancer cell lines.
        
        Radiat. Environ. Biophys. 58, 433-438 (2019)
    
    
    
				Supplementation with the antioxidant selenium is frequently performed in breast cancer patients to protect the normal tissue from radiation-induced side effects. However, concerns exist whether selenium also protects tumor cells from radiation-induced cell kill and thereby reduces the efficacy of radiotherapy. In this work, the effect of selenium administration on the radiosensitivity of breast cancer cells was evaluated in vitro. Physiological relevant selenium concentrations (70 and 140 mu g/l) did not affect DNA double-strand breaks (gamma H2AX foci) after 4-Gy X-ray irradiation. Also apoptosis (caspase 3/7) after irradiation with 10Gy was not influenced by selenium treatment in MDA-MB-231 and MCF7 cells. Most importantly, selenium supplementation did not impair the clonogenic survival of the breast cancer cell lines after irradiation (0, 2, 4, 6, 8Gy). The data suggest that physiological relevant selenium concentrations administered in combination with radiation therapy do not deteriorate the efficacy of radiotherapy in breast cancer patients. However, randomized clinical trials comparing the effectiveness of radiotherapy and the associated side effects in patients with and without selenium supplementation are recommended.
			
			
		Impact Factor
					Scopus SNIP
					Web of Science
Times Cited
					Times Cited
Scopus
Cited By
					
					Cited By
Altmetric
					
				1.267
					0.837
					2
					5
					
					
				Anmerkungen
				
					
						 
						
					
				
			
				
			
				Besondere Publikation
				
					
						 
					
				
			
			
			
				Auf Hompepage verbergern
				
					
						 
					
				
			
			
        Publikationstyp
        Artikel: Journalartikel
    
 
    
        Dokumenttyp
        Wissenschaftlicher Artikel
    
 
     
    
    
        Schlagwörter
        Selenium ; Radiation ; Breast Cancer ; Radiosensitivity ; Antioxidant ; Supplementation; Sodium Selenite; Serum-levels; Lung-cancer; Tumor-cells; Radiation; Supplementation; Prevention; Modulation; Oncology; Oxygen
    
 
     
    
    
        Sprache
        
    
 
    
        Veröffentlichungsjahr
        2019
    
 
     
    
        HGF-Berichtsjahr
        2019
    
 
    
    
        ISSN (print) / ISBN
        0301-634X
    
 
    
        e-ISSN
        1432-2099
    
 
     
     
     
	     
	 
	 
    
        Zeitschrift
        Radiation and Environmental Biophysics
    
 
		
    
        Quellenangaben
        
	    Band: 58,  
	    Heft: 3,  
	    Seiten: 433-438 
	    
	    
	
    
 
  
         
        
            Verlag
            Springer
        
 
        
            Verlagsort
            233 Spring St, New York, Ny 10013 Usa
        
 
	
         
         
         
         
         
	
         
         
         
    
         
         
         
         
         
         
         
    
        Begutachtungsstatus
        Peer reviewed
    
 
    
        Institut(e)
        Institute of Radiation Medicine (IRM)
    
 
    
        POF Topic(s)
        30203 - Molecular Targets and Therapies
    
 
    
        Forschungsfeld(er)
        Radiation Sciences
    
 
    
        PSP-Element(e)
        G-501300-001
    
 
     
     	
    
    
        WOS ID
        WOS:000474439000012
    
    
        Scopus ID
        85067670641
    
    
        PubMed ID
        31201502
    
    
        Erfassungsdatum
        2019-06-24